SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells

17:42 EDT 1 Jun 2018 | Nature Publishing

More From BioPortfolio on "SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells"